APVO · Aptevo Therapeutics Inc.
AI read · Good for APVO
The AI's read
Fewer reactions may make mipletamig easier for patients to receive. The filing gives no reaction counts or other trial results, so this report does not show the size of the improvement or its effect on treatment outcomes.